Everolimus in Pancreatic Neuroendocrine Tumors
0 Views
administrator
07/09/23
Rodney F. Pommier, MD, reviews findings from the RADIANT-1 study that explored everolimus as a treatment for patients with advanced pancreatic neuroendocrine tumors.
For more from this discussion, visit http://www.onclive.com/peer-ex....change/pancreatic-ne
Show more
Facebook Comments
No comments found